Sarasota Memorial thyroid/parathyroid specialist Ralph P. Tufano, MD, MBA, FACS, has been recognized among a panel of leading medical experts who have issued new guidelines for the treatment of differentiated thyroid cancer (DTC), the most prevalent cancer of the thyroid.
Friday, September 5, 2025
A new study published in the American Journal of Lifestyle Medicine shows that Sarasota Memorial’s RENEW Program significantly improves weight, blood pressure and overall quality of life, offering a powerful new model for preventing hypertension, type 2 diabetes, obesity, stroke, heart disease and other chronic diseases.
Friday, September 5, 2025
Sarasota Memorial Hospital has been ranked #1 in the nation for preventing readmissions among heart bypass patients, according to Becker’s Hospital Review, with federal data showing SMH with the lowest rate of unplanned hospital visits following coronary artery bypass graft (CABG) surgery of all hospitals evaluated.
Thursday, September 4, 2025
Women with advanced or recurring ovarian, peritoneal, or fallopian tube cancer may be eligible to participate in a new clinical trial offered by Sarasota Memorial’s Kolschowsky Research and Education Institute.
Tuesday, August 26, 2025
In 2025, roughly 313,780 men in the US will learn they have prostate cancer and 35,770 will die from it. Since 2014, that rate has only been increasing. But a new targeted therapy called Pluvicto is changing the game.
Tuesday, August 26, 2025